Related by context. Frequent words. (Click for all words.) 61 Atiprimod 61 pertuzumab 60 relapsed refractory multiple myeloma 60 Amrubicin 60 metastatic renal cell carcinoma 59 metastatic hormone refractory 59 CA4P 59 pheochromocytoma 59 myeloproliferative disorders 58 Voreloxin 58 L Annamycin 58 relapsed refractory 58 Phase Ib clinical 58 cutaneous T cell 58 chronic myeloid leukemia CML 58 Cloretazine R VNP#M 57 medullary thyroid cancer 57 registrational 57 HER2 positive metastatic breast 57 IV melanoma 56 lymphoma CTCL 56 chronic myelogenous leukemia CML 56 neuroendocrine tumors 56 hematologic malignancies 56 granulocyte colony stimulating 55 myelofibrosis 55 double blinded placebo 55 myelodysplastic syndrome MDS 55 Acute Myeloid Leukemia AML 55 Ph + ALL 54 glioblastoma multiforme GBM 54 heavily pretreated 54 tezampanel 54 hepatocellular carcinoma HCC 54 Metastatic Melanoma 54 placebo controlled Phase 53 registrational trial 53 indolent NHL 53 metastatic liver 53 Chronic Lymphocytic Leukemia 53 sapacitabine 53 systemic lupus erythematosus 53 aHUS 53 unresectable 52 cardiac dysfunction 52 renal cell carcinoma 52 Phase 1b clinical 52 Duchenne muscular dystrophy DMD 51 acute coronary syndromes ACS 51 Acute Myeloid Leukemia 51 QNEXA 50 breast carcinoma 50 RRMS patients 50 palifosfamide 50 medulloblastoma 50 Duchenne Muscular Dystrophy DMD 50 placebo controlled clinical 50 Phase 1b 49 hematologic cancers 49 Glioma 49 deforolimus 49 Systemic Lupus Erythematosus 49 cholangiocarcinoma 49 acute myelogenous leukemia AML 49 relapsing remitting multiple sclerosis 49 Restanza 48 Metastatic 48 astrocytoma 48 soft tissue sarcomas 48 prospective multicenter 48 nasopharyngeal cancer 48 Carcinoma 47 acute myeloid leukemia AML 47 polycythemia vera 47 glioblastoma 47 sarcomas 47 Thrombocytopenia 46 relapsing remitting MS 46 factor VEGF 46 carcinomas 46 neuroendocrine cancer 46 acute myeloid leukemia 46 blinded placebo controlled 46 Phase III Trial 46 purpura 46 infantile spasms 46 brain metastases 45 CTCL 45 Multicenter 45 pleural mesothelioma 45 Glioblastoma 45 ependymoma 45 label dose escalation 45 relapsing remitting 44 randomized Phase III 44 Non Hodgkin Lymphoma 44 taspoglutide 44 metastatic cancer 44 multicenter randomized double 44 cell signaling pathways 43 myelodysplastic syndrome